Cargando…

DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality

AIMS/HYPOTHESIS: The double-blind Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients with Type 2 Diabetes at High Risk of Cardiovascular Events (DEVOTE) assessed the cardiovascular safety of insulin degludec. The incidence and rates of adjudicated severe hypogl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pieber, Thomas R., Marso, Steven P., McGuire, Darren K., Zinman, Bernard, Poulter, Neil R., Emerson, Scott S., Pratley, Richard E., Woo, Vincent, Heller, Simon, Lange, Martin, Brown-Frandsen, Kirstine, Moses, Alan, Barner Lekdorf, Jesper, Lehmann, Lucine, Kvist, Kajsa, Buse, John B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002964/ https://www.ncbi.nlm.nih.gov/pubmed/28913543 http://dx.doi.org/10.1007/s00125-017-4422-0

Ejemplares similares

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)
por: Zinman, Bernard, et al.
Publicado: (2017)

Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE
por: Heller, Simon, et al.
Publicado: (2020)

Development of a hypoglycaemia risk score to identify high‐risk individuals with advanced type 2 diabetes in DEVOTE
por: Heller, Simon, et al.
Publicado: (2020)

Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7)
por: Pratley, Richard E., et al.
Publicado: (2019)

Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)
por: Brown‐Frandsen, Kirstine, et al.
Publicado: (2019)

Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE
por: Klein, Klara R, et al.
Publicado: (2021)

Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: An exploratory analysis (DEVOTE 12)
por: Amod, Aslam, et al.
Publicado: (2020)

Glomerular Filtration Rate and Associated Risks of Cardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes: Secondary Analysis (DEVOTE 11)
por: Amod, Aslam, et al.
Publicado: (2019)

Short‐term cost‐utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9)
por: Pollock, Richard F., et al.
Publicado: (2019)

Abstract 4: Derived time-in-range is associated with major adverse cardiovascular event in T2D: Data from the DEVOTE trial
por: Pathan, Muzammil Khan A, et al.
Publicado: (2022)

Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14
por: Pratley, Richard E., et al.
Publicado: (2019)

Long-term Cost-effectiveness of Insulin Degludec Versus Insulin Glargine U100 in the UK: Evidence from the Basal-bolus Subgroup of the DEVOTE Trial (DEVOTE 16)
por: Pollock, Richard F., et al.
Publicado: (2019)

Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used
por: Norwood, Paul, et al.
Publicado: (2017)

Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real‐world studies
por: Pedersen‐Bjergaard, Ulrik, et al.
Publicado: (2018)

Increased Derived Time in Range Is Associated with Reduced Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and Microvascular Events in Type 2 Diabetes: A Post Hoc Analysis of DEVOTE
por: Bergenstal, Richard M., et al.
Publicado: (2023)

Regional variations in definitions and rates of hypoglycaemia: findings from the global HAT observational study of 27 585 people with Type 1 and insulin‐treated Type 2 diabetes mellitus
por: Khunti, K., et al.
Publicado: (2018)

Devotion
por: McLaughlin, John, 1942-
Publicado: (1992)

A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia
por: Heller, S., et al.
Publicado: (2015)

Prototype of an evidence‐based tool to aid individualized treatment for type 2 diabetes
por: Buse, John B., et al.
Publicado: (2021)

DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK
por: Pollock, Richard F., et al.
Publicado: (2018)

Devotion to Duty
Publicado: (1906)

Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER and SUSTAIN‐6 cardiovascular outcomes trials
por: Kahkoska, Anna R., et al.
Publicado: (2020)

Devotion for newborn children
por: Purcarea, VL
Publicado: (2016)

Devotions upon emergent occasions
Publicado: (1977)

Reducing the burden of hypoglycaemia in people with diabetes through increased understanding: design of the Hypoglycaemia REdefining SOLutions for better liVEs (Hypo‐RESOLVE) project
por: de Galan, B. E., et al.
Publicado: (2020)

The Ordinary Devoted Mother and Her Baby
Publicado: (1950)

Ramadan: devotion, compassion, and purification in Sydney
por: Possamai, Adam, et al.
Publicado: (2022)

NIV women's devotional Bible : New International Version.
Publicado: (1990)

Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials
por: Verma, Subodh, et al.
Publicado: (2020)

The role of structured education in the management of hypoglycaemia
por: Iqbal, Ahmed, et al.
Publicado: (2017)

Special Public Meeting devoted to Associated Members of personnel
por: Staff Association
Publicado: (2022)

In TFIIH, XPD Helicase Is Exclusively Devoted to DNA Repair
por: Kuper, Jochen, et al.
Publicado: (2014)

Constant dedication, passion and devotion for the patients with neurological affections
por: Purcarea, VL
Publicado: (2015)

Hopefully devoted to Q: targeting glutamine addiction in cancer
por: Still, Emma R, et al.
Publicado: (2017)

Inpatient psychiatry unit devoted to COVID-19 patients
por: Mahgoub, Nahla, et al.
Publicado: (2021)

Elisa Estenssoro: a career devoted to critical care
por: Kirby, Tony
Publicado: (2021)

North-Western Educator: Devoted to Education, Liter., &c.
Publicado: (1847)

Hypoglycæmia
Publicado: (1934)

Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study
por: Koehler, Gerd, et al.
Publicado: (2013)

Is there a need for a new journal devoted to preventive medicine?
por: Franco, Eduardo L., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9h7brvnq7a4qemjheju7i5c22e